(PharmaNewsWire.Com, August 04, 2020 ) Growth in the global centesis catheters market can be attributed to factors such as the rising target patient population (particularly patients suffering from cancer, TB, and cardiovascular diseases), growing preference for image-guided centesis procedures,...
(PharmaNewsWire.Com, August 04, 2020 ) The demand for in-vitro diagnostic products due to the COVID-19 pandemic is expected to increase mainly due to factors such as a sharp rise in market demand for PCR, NGS, serology based rapid-test products, the supportive regulatory landscape for product development...
(PharmaNewsWire.Com, August 04, 2020 ) Major factors driving the growth of this neurovascular devices market include growing target patient population, ongoing product development & commercialization, favorable medical reimbursements, expansion of healthcare infrastructure across emerging markets,...
(PharmaNewsWire.Com, August 04, 2020 ) Market DynamicsEmergence of next-generation ablation products and significant adoption of minimally invasive procedures coupled with increasing number of ablation procedures are the key factors driving the growth of the global ablation devices market. Furthermore,...
(PharmaNewsWire.Com, August 03, 2020 ) The major factors that are expected to be driving the genotyping assay market are technological advancements and the decreasing prices of DNA sequencing. The increasing incidence of genetic diseases and rising awareness of personalized medicine, growing importance...
(PharmaNewsWire.Com, August 01, 2020 ) Factors contributing to the growth of this market include the increasing incidence of chronic diseases, increasing automation in laboratories, rising geriatric population, and increasing healthcare expenditure.[140 Pages Report] The slide stainer market was...
(PharmaNewsWire.Com, August 03, 2020 ) The market growth is largely driven by factors such as growing funding for cell-based research, rising incidence of chronic and infectious diseases, growing biotechnology and biopharmaceutical industries, the development of enhanced solutions and improved image...
(PharmaNewsWire.Com, July 31, 2020 ) Real-world evidence is the clinical evidence regarding the usage and potential benefits or risks of a medical product derived from the analysis of real-world data. Real-world data (RWD) is defined as data derived from a number of sources that are associated with...
(PharmaNewsWire.Com, July 31, 2020 ) According to a new market research report “Lung Cancer Surgery Market by Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy), Minimally Invasive), Device (Surgical (Clamps, Forceps, Retractors, Stapler), Monitoring (Camera, Trocar), Endoscopic Instrument)...
(PharmaNewsWire.Com, July 31, 2020 ) The global vascular closure devices market is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%. The increasing interventional procedures using radial access, the high cost of vascular closure devices, and the risks...
(PharmaNewsWire.Com, July 31, 2020 ) The global angiography equipment market is projected to reach USD 13.06 Billion by 2023 from USD 10.26 Billion in 2018, at a CAGR of 5.0%. The growth in this market is attributed to the high prevalence of diseases such as cancer and CVDs, increasing product approvals...
(PharmaNewsWire.Com, July 31, 2020 ) According to a new market research report “Endodontics Market by Instruments (Scalers, Apex Locator, Motors, Handpiece, Laser), Consumables (Access Cavity Preparation, Endodontic Files, Burs, Drill, Lubricant, Obturation), End User (Clinic, Hospital) – Global...
(PharmaNewsWire.Com, July 31, 2020 ) The global immunotherapy drugs market is projected to reach USD 274.6 billion by 2025 from USD 163.0 billion in 2020, at a CAGR of 11.0% during the forecast period. The growth of this market is majorly attributed to the increasing adoption of immunotherapy drugs...
(PharmaNewsWire.Com, July 31, 2020 ) Growth in this market is driven by the rising global prevalence of hematologic cancer, growing awareness regarding personalized medicines, and increasing collaborations for developing new assays.What the Hemato Oncology Testing Market Looks Like?The Hemato oncology...
(PharmaNewsWire.Com, July 31, 2020 ) The major factors that are expected to be driving the high content screening market are need for cost containment in pharma R&D, growth in funding for cellular research, and technological advancements in HCS solutions are expected to support the growth of the...
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
